RespireRx Pharmaceuticals Inc (RSPI)

[atheroprevent]

Actually Hay, this board is now the only source of Corx info for me, meager as it is.

It is interesting that you chose to ignore the most obvious fact. Corx valuation is such that the IP and patents could be aquired by pharma for pocket change. Who has stepped forward previously or recently? Why not?

Clearly, as Enemem has stated, the development cost and risk remain too high, regardless of ampa valuation.

If being an apologist for management means reserving judgment, I am guilty. Based on your view, Hay, I think we would have had numerous board changes during Cor life, because Cor never had a winning season. Do you think board change would have changed ampa development?